Search results
Flightpath Biosciences BizSpotlight - Boston Business Journal
The Business Journals· 7 days agoFlightpath Biosciences Inc., a clinical-stage life sciences company announced today that the first healthy volunteers have been dosed in its Phase I clinical trial of FP-100 (hygromycin A), ...
Wisdom gains value as the price of intelligence drops
Fast Company Magazine· 9 hours agoThe data flooding industries globally is staggering—from genomic sequences in healthcare to consumer...
Borowitz Oversaw Key CF Research Breakthroughs
UB Reporter· 2 days agoBorowitz says the newest medication has dramatically changed the course of the disease for many, though not all, people with CF. “People with CF did not live beyond childhood when Dr. Erika ...
Nobel laureate shares vision for molecular machines at Fudan University
China Daily· 6 days agoBernard Lucas Feringa, the 2016 Nobel laureate in chemistry, presented his pioneering work constructing molecular machines that operate on tiny scales at a lecture at Fudan University on Friday ...
Amgen plows ahead with costly, highly toxic cancer dosing despite FDA challenge
Chicago Sun-Times· 7 days agoWhen doctors began using the drug sotorasib in 2021 with high expectations for its innovative approach to attacking lung cancer, retired medical technician Don Crosslin was an early beneficiary. Crosslin started the drug that July.
Persistent strain of cholera defends itself against forces of change, scientists find
Phys.org· 3 days agoFinally, in a study published in Nature, researchers from The University of Texas at Austin have...
Lawn sprinklers expose Utah kids to water contaminated with E. coli
UPI· 6 days agoHappily jumping around lawn sprinklers on a hot summer day: An idyllic childhood scene. Not so for...
NRx Pharmaceuticals (Nasdaq:NRXP) Reports First Quarter 2024 Financial Results and Provides Business...
Rome Sentinel· 2 days agoPositive data from a Phase 2b/3 trial of NRX-101 in Treatment Resistant Bipolar Depression (TRBD); trial demonstrated depression efficacy comparable to standard of care and significant reduction ...
